Cargando…

Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency

BACKGROUND: Nephrotic syndrome confers an acquired prothrombotic phenotype due to the urinary loss of anticoagulant proteins.Patients with reactivation of nephrotic syndrome may develop thrombosis. CASE PRESENTATION: We report the case of a life-threatening cerebral venous thrombosis in a 13 year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Artoni, Andrea, Passamonti, Serena Maria, Edefonti, Alberto, Gianniello, Francesca, Civelli, Vittorio, Martinelli, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770702/
https://www.ncbi.nlm.nih.gov/pubmed/26928822
http://dx.doi.org/10.1186/s13052-016-0227-x
_version_ 1782418315781603328
author Artoni, Andrea
Passamonti, Serena Maria
Edefonti, Alberto
Gianniello, Francesca
Civelli, Vittorio
Martinelli, Ida
author_facet Artoni, Andrea
Passamonti, Serena Maria
Edefonti, Alberto
Gianniello, Francesca
Civelli, Vittorio
Martinelli, Ida
author_sort Artoni, Andrea
collection PubMed
description BACKGROUND: Nephrotic syndrome confers an acquired prothrombotic phenotype due to the urinary loss of anticoagulant proteins.Patients with reactivation of nephrotic syndrome may develop thrombosis. CASE PRESENTATION: We report the case of a life-threatening cerebral venous thrombosis in a 13 year-old boy affected by a relapse of nephrotic syndrome during a P. aeruginosa otitis/mastoiditis. Due to the worsening general conditions and the severe neurological impairment, a course of systemic thrombolysis was successfully administered, followed by anticoagulant therapy. In the present case severe inherited thrombophilia (inherited dysfunctional protein S deficiency) was identified as an important additional risk factors for thrombosis. CONCLUSIONS: A careful evalutaion of risk factos for thrombosi during reactivation of nephrotic syndrome include measurement of plasma anticaogulant proteins. When low, antithrombotic prophylaxis with heparin should be considered to prevent thrombotic episodes.
format Online
Article
Text
id pubmed-4770702
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47707022016-03-01 Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency Artoni, Andrea Passamonti, Serena Maria Edefonti, Alberto Gianniello, Francesca Civelli, Vittorio Martinelli, Ida Ital J Pediatr Case Report BACKGROUND: Nephrotic syndrome confers an acquired prothrombotic phenotype due to the urinary loss of anticoagulant proteins.Patients with reactivation of nephrotic syndrome may develop thrombosis. CASE PRESENTATION: We report the case of a life-threatening cerebral venous thrombosis in a 13 year-old boy affected by a relapse of nephrotic syndrome during a P. aeruginosa otitis/mastoiditis. Due to the worsening general conditions and the severe neurological impairment, a course of systemic thrombolysis was successfully administered, followed by anticoagulant therapy. In the present case severe inherited thrombophilia (inherited dysfunctional protein S deficiency) was identified as an important additional risk factors for thrombosis. CONCLUSIONS: A careful evalutaion of risk factos for thrombosi during reactivation of nephrotic syndrome include measurement of plasma anticaogulant proteins. When low, antithrombotic prophylaxis with heparin should be considered to prevent thrombotic episodes. BioMed Central 2016-02-29 /pmc/articles/PMC4770702/ /pubmed/26928822 http://dx.doi.org/10.1186/s13052-016-0227-x Text en © Artoni et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Artoni, Andrea
Passamonti, Serena Maria
Edefonti, Alberto
Gianniello, Francesca
Civelli, Vittorio
Martinelli, Ida
Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title_full Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title_fullStr Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title_full_unstemmed Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title_short Antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein S deficiency
title_sort antithrombotic prophylaxis in a patient with nephrotic syndrome and congenital protein s deficiency
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770702/
https://www.ncbi.nlm.nih.gov/pubmed/26928822
http://dx.doi.org/10.1186/s13052-016-0227-x
work_keys_str_mv AT artoniandrea antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency
AT passamontiserenamaria antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency
AT edefontialberto antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency
AT gianniellofrancesca antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency
AT civellivittorio antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency
AT martinelliida antithromboticprophylaxisinapatientwithnephroticsyndromeandcongenitalproteinsdeficiency